CERA

Vision Expo 2023 – Stand 6

Clinical biomarkers research

About our research

Our research aims to uncover new markers of eye disease using advanced imaging and functional tests. These markers are used to fast-track discovery of new treatments and transform eye care to prevent irreversible vision loss.

What you’ll see

Attend our demonstration on Cross Modality Annotation Software (XMAS) to get a deeper look into the layers of 3D imaging.

Talk to us about

  • How can we better predict those who are at the highest risk of vision loss from age-related macular degeneration (AMD) or glaucoma?
  • How can we better assess new interventions for AMD or glaucoma to fast-track treatment discovery?
  • How can artificial intelligence help us understand eye diseases and improve their early detection?